Get the Stockscreener App
4.92
1.03%
0.05
After Hours:
4.99
0.07
+1.42%
Foghorn Therapeutics Inc Stock (FHTX) Forecast
The Foghorn Therapeutics Inc (FHTX) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $1.8875, representing a -61.64% decrease from the current price of $4.92. The highest analyst price target is $3.693, and the lowest is $0.082.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month FHTX Price Target
Average 2.4821
(-49.55% Downside)
Is Foghorn Therapeutics Inc (FHTX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 71.91 | Sell |
| STOCH(9,6) | 79.69 | Neutral |
| STOCHRSI(14) | 94.98 | Sell |
| MACD(12,26) | 0.5341 | Buy |
| ADX(14) | 34.60 | Buy |
| William %R | -18.12 | Sell |
| CCI(14) | 63.90 | Neutral |
Buy: 2
Sell: 3
Neutral: 2
Summary: Sell
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
6.685
Buy
|
6.6018
Buy
|
| MA20 |
5.859
Buy
|
6.1466
Buy
|
| MA50 |
5.2726
Buy
|
5.503
Buy
|
| MA100 |
4.8859
Buy
|
5.1826
Buy
|
| MA200 |
5.0281
Buy
|
5.0152
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, FHTX could be considered a Strong Buy, with 17 technical analysis indicators signaling 12 Buy signals, 3 signaling Sell signals and 2 Neutral signals. This might be a good time to open fresh positions on FHTX, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 71.91 indicates that FHTX is overbought. This suggests that FHTX price has experienced a significant increase over a specified lookback period, potentially leading to a correction.
- STOCH (Stochastic Oscillator): The STOCH value of 79.69 indicates that FHTX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 94.98 indicates that FHTX is oversold. This suggests that FHTX price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 34.6 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 63.9 indicates that FHTX is still overbought but not to an extreme extent.
Long-term FHTX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Foghorn Therapeutics Inc financial reports and earnings history, Foghorn Therapeutics Inc (FHTX) stock could reach $3.9809 by 2030, $8.8001 by 2040 and $35.74 by 2050. See the projected annual prices until 2050 of the Foghorn Therapeutics Inc stock below:
- Foghorn Therapeutics Inc (FHTX) is expected to reach an average price of $10.75 in 2035, with a high prediction of $10.88 and a low estimate of $10.37. This indicates an $118.48% rise from the last recorded price of $4.92.
- Foghorn Therapeutics Inc (FHTX) stock is projected to chart a bullish course in 2040, with an average price target of $9.4751, representing an $92.58% surge from its current level. The forecast ranges from a conservative $8.4716 to a sky-high $8.8001.
- Our analysts predict Foghorn Therapeutics Inc (FHTX) to jump 696.64% by 2045, soaring from $40.48 to an average price of $39.19, potentially reaching $42.80. While $40.48 is the low estimate, the potential upside is significant.
- Foghorn Therapeutics Inc (FHTX) stock is expected to climb by 2050, reaching an average of $34.85, a $608.28% jump from its current level. However, a wide range of estimates exists, with high and low targets of $35.74 and $35.12, respectively, highlighting the market's uncertainty.
Foghorn Therapeutics Inc Stock (FHTX) Year by Year Forecast
Foghorn Therapeutics Inc Stock (FHTX) Price Forecast for 2026
The predicted value for Foghorn Therapeutics Inc (FHTX) in 2026 is set at an average of $5.6114. Estimates vary from a peak of $11.19 to a trough of $0.0337, indicating an +14.05% surge from the present price of $4.92.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| October, 2026 | $1.744 | $0.082 | $3.693 | -64.55% |
| November, 2026 | $1.4078 | $0.6278 | $3.3168 | -71.39% |
| December, 2026 | $0.5474 | $0.2212 | $1.3488 | -88.87% |
Foghorn Therapeutics Inc Stock (FHTX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Foghorn Therapeutics Inc (FHTX) is $2.4821, with a high forecast of $4.8966 and a low forecast of $0.0676. This indicates an -49.55% decrease from the last price of $4.92.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.1365 | $0.0735 | $0.7055 | -97.23% |
| February, 2027 | $0.4503 | $0.0676 | $1.8774 | -90.85% |
| March, 2027 | $1.6551 | $0.4807 | $1.6732 | -66.36% |
| April, 2027 | $1.7189 | $1.5089 | $3.898 | -65.06% |
| May, 2027 | $3.8428 | $1.2499 | $4.0128 | -21.89% |
| June, 2027 | $2.0576 | $1.6777 | $4.8966 | -58.18% |
| July, 2027 | $1.5914 | $1.4114 | $3.0836 | -67.65% |
| August, 2027 | $1.3047 | $0.1234 | $1.7155 | -73.48% |
| September, 2027 | $1.4099 | $1.4599 | $1.3328 | -71.34% |
| October, 2027 | $0.0261 | $0.3761 | $0.179 | -99.47% |
| November, 2027 | $2.0578 | $0.0951 | $2.4978 | -58.18% |
| December, 2027 | $1.0574 | $0.5193 | $2.3337 | -78.51% |
Foghorn Therapeutics Inc Stock (FHTX) Price Forecast for 2028
In 2028, Foghorn Therapeutics Inc (FHTX) is projected to reach an average price of $4.251, with a high projection of $8.4585 and a low estimate of $0.0435. This indicates an -13.60% fall from the last price of $4.92.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $1.8664 | $1.3065 | $3.2555 | -62.06% |
| February, 2028 | $1.9203 | $1.792 | $4.3883 | -60.97% |
| March, 2028 | $1.4651 | $1.3051 | $4.1841 | -70.22% |
| April, 2028 | $4.26 | $0.996 | $3.53 | -13.41% |
| May, 2028 | $0.2796 | $1.2623 | $3.8681 | -94.32% |
| June, 2028 | $0.5873 | $0.0435 | $8.4585 | -88.06% |
| July, 2028 | $2.935 | $0.8269 | $5.665 | -40.35% |
| August, 2028 | $5.4154 | $2.7512 | $2.1973 | +10.07% |
| September, 2028 | $5.6977 | $6.2577 | $5.0635 | +15.81% |
| October, 2028 | $6.96 | $6.3158 | $6.39 | +41.46% |
| November, 2028 | $7.9104 | $8.0681 | $8.1943 | +60.78% |
| December, 2028 | $7.7827 | $7.8066 | $6.8685 | +58.19% |
Foghorn Therapeutics Inc Stock (FHTX) Price Forecast for 2029
The 2029 price forecast for Foghorn Therapeutics Inc Stock (FHTX) is $4.1958 on average, with a high prediction of $8.3693 and a low estimate of $0.0224. This represents an -14.72% decrease from the previous price of $4.92.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $8.0931 | $7.7834 | $7.7231 | +64.49% |
| February, 2029 | $7.1854 | $8.4771 | $8.3693 | +46.05% |
| March, 2029 | $3.3478 | $4.7651 | $5.3435 | -31.96% |
| April, 2029 | $2.8201 | $3.2701 | $3.1158 | -42.68% |
| May, 2029 | $2.9005 | $4.5971 | $3.9143 | -41.05% |
| June, 2029 | $4.8928 | $3.5685 | $2.5728 | -0.55% |
| July, 2029 | $4.9849 | $1.017 | $5.7799 | +1.32% |
| August, 2029 | $1.8755 | $0.2907 | $8.2488 | -61.88% |
| September, 2029 | $5.1378 | $1.8735 | $2.6278 | +4.43% |
| October, 2029 | $1.1782 | $4.8582 | $5.2039 | -76.05% |
| November, 2029 | $0.7095 | $0.0224 | $2.1645 | -85.58% |
| December, 2029 | $3.8528 | $0.9266 | $2.3228 | -21.69% |
Foghorn Therapeutics Inc Stock (FHTX) Price Forecast for 2030
Foghorn Therapeutics Inc Stock (FHTX) is expected to reach an average price of $2.9915 in 2030, with a high forecast of $5.9808 and a low forecast of $0.00218. This signifies an -39.20% decrease from the last price of $4.92.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $1.7932 | $2.3751 | $3.9809 | -63.55% |
| February, 2030 | $0.6955 | $1.6855 | $1.0187 | -85.86% |
| March, 2030 | $0.2722 | $0.00218 | $1.9321 | -94.47% |
| April, 2030 | $1.9599 | $0.044 | $4.258 | -60.17% |
| May, 2030 | $4.8905 | $3.7563 | $2.9144 | -0.60% |
| June, 2030 | $5.8328 | $5.3348 | $4.4486 | +18.55% |
| July, 2030 | $4.4532 | $4.7651 | $4.7609 | -9.49% |
| August, 2030 | $5.5155 | $4.9813 | $5.3455 | +12.10% |
| September, 2030 | $6.0578 | $6.4036 | $5.8998 | +23.13% |
| October, 2030 | $3.5282 | $3.7082 | $5.2459 | -28.29% |
| November, 2030 | $6.2306 | $3.8563 | $5.5506 | +26.64% |
| December, 2030 | $6.3229 | $6.2167 | $5.9808 | +28.51% |
0.86%
0.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):